Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qianlie Huikang Pian for benign prostatic hyperplasia
CTR20130166Phase 2Suspended
- Sponsor
- Tonghua Tianli Pharmaceutical
- Start
- Jan 2014
- Countries
- 1
01
Overview
A Phase 2 trial of qianlie huikang in benign prostatic hyperplasia (BPH), sponsored by Tonghua Tianli Pharmaceutical. Started Jan 2014; status: suspended.
02
Drugs
qianlie huikang
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on CTR20130166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130166.